MedDevNews, Q3 2024
Q3 2024 saw the organ transplant market thriving, driven by rising demand and advanced preservation technologies, and the IPO market rebounded, reflecting investor enthusiasm for AI-enabled diagnostics. M&A activity is recovering, with OEM transaction volumes increasing year-over-year and CMO transactions gradually improving despite declining investment activity. England also attended the Women’s Health Innovation Summit in September and has launched a new Women’s Health sector breakout for market performance analyses. This edition also offers insights on the upcoming election and its potential impacts on medical device markets.
England also announced the strategic sale of Collagen Solutions, a leader in medical-grade collagen and tissue-based biomaterials, to RTI Surgical, a leading tissue engineering CDMO.